Calcium Sulfate Based Bioactive Bone Graft
硫酸钙基生物活性骨移植物
基本信息
- 批准号:7830703
- 负责人:
- 金额:$ 19.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-08 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAllograftingAnimal ModelAutologous TransplantationBecaplerminBenignBiocompatibleBioglassBlood VesselsBone GrowthBone Morphogenetic ProteinsBone RegenerationBone TransplantationCalcium SulfateCarbonatesCell Culture TechniquesCellsChemical StructureCollagenDefectDentalDental ImplantsDentistryDentistsDevelopmentEffectivenessExcisionFDA approvedFaceFeasibility StudiesFillerFractureGrantGrowth FactorHarvestHemostatic AgentsHumanIn VitroJawKineticsMaintenanceMalignant NeoplasmsMarketingMarrowMesenchymalNon-Steroidal Anti-Inflammatory AgentsOrgan TransplantationOrthopedicsOsteogenesisPatientsPeriodontal PocketPhasePhase I Clinical TrialsPlatelet-Derived Growth FactorPolymersProcessPropertyRecombinantsRecording of previous eventsResearchSafetySinusSiteSmall Business Innovation Research GrantStem cellsTissuesTooth LossTransplanted tissueWorkallogenic bone transplantationbasebiocompatible polymerbiomaterial compatibilitybonebone growth factorbone morphogenetic protein 7calcium phosphateimprovedin vivointerestmaxillofacialnew growthprocollagen C-endopeptidasepublic health relevancerecombinant human bone morphogenetic protein-2responsetricalcium phosphatevasculogenesis
项目摘要
DESCRIPTION (provided by applicant): The aim of this research is to develop an improved, synthetic bone graft material for use in dentistry. The loss of teeth is often accompanied by the loss of jaw bone. Restoring this lost bone is often a prerequisite for the installation of dental implants and the maintenance of normal facial features. Calcium sulfate works quite well as a bone regeneration material. It serves not only as a defect filler, but is also biocompatible, conducts new bone growth and encourages the growth of new blood vessels. However, its fast degradation is its major shortcoming, restricting its use in bone grafting applications. Based upon a successful phase I feasibility study, this project proposes the development of a new material: a calcium sulfate/absorbable polymer composite with superior biocompatibility and bone-compatibility and bone growth factor delivery capability. Phase I studies have already demonstrated that calcium sulfate/ absorbable polymer composites undergo slower degradation than pure calcium sulfate and thus overcomes a significant drawback of this material as a bone regeneration product. The plan now is to develop a product that dentists can use in bone grafting procedures that will rival the bone regeneration potential seen with the use of the patients' own harvested bone. The product, a composite of calcium sulfate and Poly DTE carbonate that delivers a bone growth factor, rhBMP-2, utilizes a new polymer whose in vivo bone response has been studied in several animal models. Because of its specific chemical structure, this polymer elicits an excellent cell and tissue response. Since an earlier version of this product has already been commercialized, this new product will be rapidly introduced to the marketplace as an improved replacement.
PUBLIC HEALTH RELEVANCE: Bone grafting is an essential component of facial and dental maintenance. Recent concern about allograft bone supply makes the development of a reliable, affordable synthetic essential to this process. This project describes the development of just such a synthetic with bone regeneration capability rivaling autografts based on a simple, affordable material with a long safety history, calcium sulfate, combined with a new highly bone-compatible and biocompatible polymer and a bone growth factor.
描述(由申请人提供):本研究的目的是开发一种用于牙科的改进的合成骨移植材料。牙齿的缺失常常伴随着颌骨的缺失。恢复丢失的骨质通常是安装牙种植体和维持正常面部特征的先决条件。硫酸钙作为骨再生材料效果很好。它不仅可以作为缺陷填充剂,而且具有生物相容性,可以促进新骨生长并促进新血管生长。然而,其快速降解是其主要缺点,限制了其在骨移植应用中的使用。基于成功的一期可行性研究,该项目建议开发一种新材料:硫酸钙/可吸收聚合物复合材料,具有优异的生物相容性和骨相容性以及骨生长因子输送能力。第一阶段的研究已经表明,硫酸钙/可吸收聚合物复合材料的降解速度比纯硫酸钙慢,从而克服了该材料作为骨再生产品的显着缺点。现在的计划是开发一种牙医可以在骨移植手术中使用的产品,该产品将与使用患者自己采集的骨所具有的骨再生潜力相媲美。该产品是硫酸钙和聚 DTE 碳酸盐的复合材料,可提供骨生长因子 rhBMP-2,采用了一种新聚合物,该聚合物的体内骨反应已在多种动物模型中进行了研究。由于其特定的化学结构,这种聚合物能够引发出色的细胞和组织反应。由于该产品的早期版本已经商业化,因此该新产品将作为改进的替代品迅速推向市场。
公众健康相关性:骨移植是面部和牙齿维护的重要组成部分。最近对同种异体移植骨供应的担忧使得开发一种可靠、负担得起的合成材料对于这一过程至关重要。该项目描述了一种具有与自体移植物相媲美的骨再生能力的合成材料的开发,该合成材料基于一种简单、负担得起且安全历史悠久的材料——硫酸钙,并结合了一种新的高度骨相容性和生物相容性聚合物和骨生长因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harold Alexander其他文献
Harold Alexander的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harold Alexander', 18)}}的其他基金
Laser-Engineered Net Shape Ti/HA Composite Implants
激光设计的净形状 Ti/HA 复合植入物
- 批准号:
6443481 - 财政年份:2002
- 资助金额:
$ 19.23万 - 项目类别:
相似国自然基金
胸腺上皮细胞在小鼠后肢同种异体复合组织移植中的免疫调节作用及相关机制研究
- 批准号:82102354
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
过表达MicroRNA-199a-3p的BMSCs来源的外泌体抑制小鼠DC功能诱导同种异体心脏移植免疫耐受的机制研究
- 批准号:82160081
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
具有靶向识别和序贯治疗功能的纳米微球对血管化同种异体复合组织移植术后免疫抑制的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于T细胞亚群分化与TLR2/TRAF6信号通路探讨ESAT-6抑制同种异体移植排斥的分子免疫机制
- 批准号:82071800
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
受体tolDC诱导的供体MHC-I抗原特异性Treg诱导同种异体器官移植免疫耐受
- 批准号:81901627
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption
开发新型骨粘合剂支架以加速骨再生并改善牙槽嵴高度维持以治疗残留牙槽嵴吸收的患者
- 批准号:
10603678 - 财政年份:2023
- 资助金额:
$ 19.23万 - 项目类别:
Novel peptide for enhancing diabetic wound healing
促进糖尿病伤口愈合的新型肽
- 批准号:
10383864 - 财政年份:2021
- 资助金额:
$ 19.23万 - 项目类别:
Novel peptide for enhancing diabetic wound healing
促进糖尿病伤口愈合的新型肽
- 批准号:
10517746 - 财政年份:2021
- 资助金额:
$ 19.23万 - 项目类别:
Ischemic Reperfusion injury in Transplantation: Role of Sphingosine 1-phosphate receptors and dendritic cells
移植中的缺血再灌注损伤:1-磷酸鞘氨醇受体和树突状细胞的作用
- 批准号:
9337445 - 财政年份:2016
- 资助金额:
$ 19.23万 - 项目类别:
Incorporation of Dexamethasone Delivery within Engineered Cartilage
将地塞米松输送纳入工程软骨中
- 批准号:
9045150 - 财政年份:2016
- 资助金额:
$ 19.23万 - 项目类别: